Applied Biology's commitment to hair science, dermatology, and women's health is evident in our extensive product pipeline.
Microbiome based Androgenetic Alopecia Therapy: Genetically engineered microbial treatment for androgenetic alopecia
Phase 1 – Q3 2018
Chemotherapy Induced Alopecia: Small molecule prophylactic treatment of CIA
Phase 1– Q4 2018
Topical Minoxidil Adjuvant Therapies: Small molecule therapies for upregulation of scalp sulfotransferase, the major enzyme deficiency in minoxidil non-responders
Traction Alopecia: Novel diagnostics and therapies to reduce hair shedding
Cicatricial Alopecia Diagnostic: Novel diagnostic device to quantify follicular inflammation
Phase 1 – Q4 2018
Cicatricial Alopecia Therapy: Small molecule therapy for mitigating follicular inflammation
De Novo Application Submitted to the US FDA
Minoxidil Response Test: A Diagnostic Device to Aid a Physician in Identifying Non-responders to Topical Minoxidil Therapy
2018 © Applied Biology, Inc. All Rights Reserved.